Tumor Biology

, Volume 35, Issue 12, pp 12575–12581 | Cite as

RETRACTED ARTICLE: The effect of chemokine CC motif ligand 19 on the proliferation and migration of hepatocellular carcinoma

  • Ke-qin Luo
  • Yi-ni Shi
  • Ji-cai Peng
Research Article


Multiple studies have shown that CC motif chemokine ligand 19 (CCL19) promotes cell proliferation in several human cancers. The aim of this study was to investigate the expression and function of CCL19 in hepatocellular carcinoma (HCC). Quantitative reverse transcription-polymerase chain reaction (qRT-PCR), Western blot, and immunohistochemistry were performed separately to detect the expression of CCL19 in HCC tissues. The expression of CCL19 and its receptor (CCR7) in different HCC cell lines were screened by Western blot. HCC cell lines were screened and processed with recombinant human CCL19 (rhCCL19) or si-CCL19 RNA. Cell proliferation assay and transwell assay were performed to evaluate the proliferation and migration of HCC cells, respectively. Low expression of CCL19 was observed in 83.72 % (72/86) of the HCC versus 16.67 % (4/24) of the adjacent non-tumorous liver tissues, the difference of CCL19 expression between HCC and adjacent non-tumorous liver tissues was statistically significant (P < 0.001). The expression level of CCL19 mRNA and protein in tumor tissues was significantly lower than adjacent non-tumorous liver tissues. The proliferation and migration of HCC cells were obviously inhibited in rhCCL19-treated groups. Our data suggest that CCL19 may play a suppressive role in the regulation of aggressiveness in human HCC.


Chemokines Chemokine receptors CCL19 CCR7 Hepatocellular carcinoma Proliferation Migration 


Conflicts of interest



  1. 1.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMedGoogle Scholar
  2. 2.
    Ades S. Adjuvant chemotherapy for colon cancer in the elderly: moving from evidence to practice. Oncology (Williston Park). 2009;23:162–7.Google Scholar
  3. 3.
    Frangov T, Gaĭdarski R, Dimitrova V, Popov V, Grozeva K, Rusenov D. Prognostic factors for survival in primary liver cancer. Khirurgiia (Sofiia). 2007;6:36–9.Google Scholar
  4. 4.
    El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–76.CrossRefPubMedGoogle Scholar
  5. 5.
    Roussos ET, Condeelis JS, Patsialou A. Chemotaxis in cancer. Nat Rev Cancer. 2011;11:573–87.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Dieu MC, Vanbervliet B, Vicari A, et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med. 1998;188:373–86.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Hamanishi J, Mandai M, Matsumura N, et al. Activated local immunity by CC chemokine ligand19-transduced embryonic endothelial progenitor cells suppresses metastasis of murine ovarian cancer. Stem Cells. 2010;28:164–73.PubMedGoogle Scholar
  8. 8.
    Johrer K, Pleyer L, Olivier A, Maizner E, Zelle-Rieser C, Greil R. Tumour-immune cell interaction smodulated by chemokines. Expert Opin Biol Ther. 2008;8:269–90.CrossRefPubMedGoogle Scholar
  9. 9.
    Wang W, Huang P, Zhang L, Wei J, Xie Q, Sun Q, et al. Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo. Cancer Sci. 2013;104:1523–31.CrossRefPubMedGoogle Scholar
  10. 10.
    Gao Q, Zhao YJ, Wang XY, Qiu SJ, Shi YH, Sun J, et al. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma. Cancer Res. 2012;72:3546–56.CrossRefPubMedGoogle Scholar
  11. 11.
    Itakura M, Terashima Y, Shingyoji M, et al. High CC chemokine receptor 7 expression improves postoperative prognosis of lung adenocarcinoma patients. Br J Cancer. 2013;109:1100–8.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Cao M, Deng HX, Zhao J, Fan LY, Jiang Y, Wen YJ, et al. Antitumour activity of cationic-liposome-conjugated adenovirus containing the CCL19 [chemokine (C-C motif) ligand 19] gene. Biotechnol Appl Biochem. 2007;48:109–16.CrossRefPubMedGoogle Scholar
  13. 13.
    Lu J, Zhao J, Feng H, Wang P, Zhang Z, Zong Y, et al. Antitumor efficacy of CC motif chemokine ligand 19 in colorectal cancer. Dig Dis Sci. 2014;59(9):2153–62.Google Scholar
  14. 14.
    Oliveira-Neto HH, de Souza PP, da Silva MR, Mendonça EF, Silva TA, Batista AC. The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis. Tumour Biol. 2013;34:65–70.CrossRefPubMedGoogle Scholar
  15. 15.
    Shang ZJ, Liu K, Shao Z. Expression of chemokine receptor CCR7 is associated with cervical lymphnode metastasis of oral squamous cell carcinoma. Oral Oncol. 2009;45:48–55.CrossRefGoogle Scholar
  16. 16.
    Kochetkova M, Kumar S, McColl S. R: Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells. Cell Death Differ. 2009;16:664–73.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  1. 1.Department of Emergency, SunYat-Sen memorial HospitalSun Yat-Sen UniversityGuangzhouChina

Personalised recommendations